Piscataway, NJ, January 26, 2022–Camber Pharmaceuticals is pleased to announce the addition of Dexmethylphenidate Hydrochloride ER Capsules to their current portfolio.
Dexmethylphenidate Capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Dexmethylphenidate Capsules from Camber are available in 5, 10, 15, 20, 25, 30, 35, 40 mg strengths. All strengths are available in 100 count bottles.
To find out more about Dexmethylphenidate Capsules please visit https://www.camberpharma.com
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
If you would like more information about this topic, please contact Megan Little at [email protected].
